Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study

Epidemiology of Myelodysplastic Syndromes

(2012) Xiaomei Ma   AMERICAN JOURNAL OF MEDICINE

Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome

(2012) Shohei Kikuchi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: A retrospective investigation on 133 patients treated in a single institution

(2011) Antonio Azzarà et al.   AMERICAN JOURNAL OF HEMATOLOGY

Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries

(2011) C. R. Cogle et al.   BLOOD

Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS

(2011) S. Park et al.   LEUKEMIA RESEARCH

Early introduction of ESA in low risk MDS patients may delay the need for RBC transfusion: A retrospective analysis on 112 patients

(2010) Sophie Park et al.   LEUKEMIA RESEARCH

An assessment of erythroid response to epoetin α as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach

(2009) Suneel Mundle et al.   CANCER

Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromes

(2009) Pellegrino Musto et al.   LEUKEMIA RESEARCH

Twice-Weekly High-Dose rHuEpo for the Treatment of Anemia in Patients with Low-Risk Myelodysplastic Syndromes

(2008) R. Latagliata et al.   ACTA HAEMATOLOGICA

Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis

(2008) Victor Moyo et al.   ANNALS OF HEMATOLOGY

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

(2008) D. E. Rollison et al.   BLOOD

Aging and erythropoiesis: Current state of knowledge

(2008) Elizabeth A. Price   BLOOD CELLS MOLECULES AND DISEASES

Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes

(2008) Janice Gabrilove et al.   BRITISH JOURNAL OF HAEMATOLOGY

Management of myelodysplastic syndromes in the geriatric patient

(2008) Ellen K. Ritchie et al.   Current Hematologic Malignancy Reports

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience

(2007) S. Park et al.   BLOOD